Some in Gloucester may be feeling a little short-changed by the United States Mint.
The federal agency this week rejected the Gloucester Fisherman’s Memorial as a national historic site to be engraved on the back of a US quarter, even though Massachusetts residents in March overwhelmingly picked the bronze statue of a fisherman holding a boat’s wheel.
Instead, the Mint will use the state’s second choice - the Lowell National Historical Park - to represent Massachusetts in its “America the Beautiful Quarters Program,’’ in which it plans to produce a series of commemorative quarters featuring national sites in each of the 56 states and territories of the United States, including Puerto Rico, the US Virgin Islands, and Guam.
EMC Corp. of Hopkinton is betting big on India as a major market for data storage hardware and software, and as a key source of first-rate engineering talent.
On Wednesday, EMC said it would invest $1.5 billion in the country over the next five years, three times as much as in the last five years. The money will be used to expand EMC’s services business, which helps businesses integrate the company’s products into their data centers. EMC will also build up its customer support operation in India, as well as research and development labs. Activities that are now hosted at multiple locations will be centralized at an EMC 60-acre “Center of Excellence’’ in Bangalore.
“India offers tremendous opportunities in innovation and market potential,’’ said EMC chief financial officer David Goulden during an opening ceremony for the newly expanded Bangalore center.
Two local employers tied to the health industry are making opposite moves on the job front - one is laying off more than 10 percent of its Massachusetts workforce, while the other wants to rapidly hire a few hundred employees.
AstraZeneca PLC, a pharmaceutical giant based in England, said it plans to cut 113 jobs at its manufacturing plant in Westborough beginning next month, largely because the company faces increased competition for the asthma medication it makes there. In March, the US Food and Drug Administration approved rival Apotex’s request to market a generic version of AstraZeneca’s Pulmicort Respules asthma drug.
“We have to be cognizant of what will be happening in the market and plan according to that,’’ said AstraZeneca spokeswoman Kate Klemas. The company also makes some other medications at the plant, including a liquid version of Nexium, the popular “purple pill’’ used to treat heartburn.
Controversy surrounding the managers of Harvard University’s gigantic endowment used to be about people making too much money, not about how many billions were lost.
More than a decade ago, Harvard started to take heat because investment managers employed by the university were earning huge performance bonuses, rewards for the enormous value they added to the endowment. Over time, Harvard farmed out more and more of its money to private investment firms and the internal compensation controversy eventually faded away.
The uproar of the moment is about the 27.3 percent loss suffered by the world’s largest university endowment in its most recent fiscal year, ended June 30. The endowment that funds about one-third of Harvard’s operating budget shrunk by a whopping $11 billion, which still left the university with $26 billion.
To read the full story, please click here.